Vineeta Agarwala, MD, PhD, is a General Partner at Andreessen Horowitz where she leads investments for the firm’s bio fund across therapeutics, diagnostics, and digital health, with a focus on companies that are leveraging unique datasets to improve drug development and patient care delivery. She also serves on the board of BigHat Biosciences.Prior to joining a16z, Vineeta has held many different roles in the healthcare space: as a physician taking care of patients; as an operator at tech-driven healthcare companies; and most recently as a venture investor on the GV (Google Ventures) life sciences team, focused on biotech companies with a data-driven approach. Previously, she was an early data scientist at Kyruus; a management consultant for biotech, pharmaceutical, and medical device clients at McKinsey & Co; and a Director of Product Management at Flatiron Health, where she led the company’s partnership with Foundation Medicine to integrate real-world clinical and genomic data into national-scale database products to accelerate drug development and research in oncology. She has collaborated with academic researchers at Cold Spring Harbor Laboratory, Lawrence Livermore National Laboratory, and the Broad Institute, where she did graduate work in computational biology and human genetics.
Vineeta holds a B.S. in biophysics from Stanford University, and MD and PhD degrees from Harvard Medical School / MIT. She completed her clinical residency at Stanford, and is board certified in internal medicine. Vineeta continues to see patients at Stanford as an adjunct clinical professor in the Division of Primary Care and Population Health.


Vineeta Agarwala, MD
Board Member
A16Z
Jeffrey is an Entrepreneur in Residence at AlleyCorp and the Founder of Groups: Recover Together, the national leader in value-based care for treatment of opiate addiction. Dr. De Flavio’s expertise is in value-based care, clinical redesign and building early-stage companies. He received his M.D. from the Dartmouth College of Medicine and his M.B.A. from the Tuck School of Business at Dartmouth.



Jeffrey De Flavio, MD
Executive Chairman
AlleyCorp | Groups
Michael served as an early employee and Vice President at Oscar Health, where he built their sales and network functions. He managed the company’s largest P&L at +$2.5B before helping take the company public with its IPO.Prior to Oscar, Michael worked for Bridgewater Associates in the company’s Research, Client Service, and Recruiting departments. While at Bridgewater, he was the Head of Research Analytics where he reported to the CEO and Ray Dalio. In 2009 he successfully sold DormAid, a college service company, which he launched and ran while he was a student at Harvard.
He is the recipient of Columbia’s Feldberg Fellowship, where he received his M.B.A. He received his A.B. from Harvard College. In 2024 he was selected as a Presidential Leadership Scholar.



Michael Kopko
Board Member, CEO
Oscar | Bridgewater
Kevin Ryan is one of the leading internet entrepreneurs and investors in New York. Alongside AlleyCorp, he co-founded MongoDB, Business Insider, Gilt Groupe, Zola, and Nomad Health, and continues to found new companies with AlleyCorp every year. Collectively, AlleyCorp companies have raised more than $2B in venture capital and employ thousands of people in New York City and beyond. On the investment side, AlleyCorp is one of the most active early stage funds in New York.Earlier in his career, Kevin helped to grow DoubleClick, first as President and then as CEO, leading their growth from a 20-person startup to a publicly traded global leader with over 1,500 employees, through IPO in 1998 and acquisition by Google in 2007.
Kevin serves on the board of Mercy Corps, is Vice Chairman of The Partnership for New York City, is a member of the CFR Committee on Foreign Affairs, is on the Board of TECH:NYC and is Director Emeritus for Human Right Watch. He previously served on the boards of the Yale Corporation, INSEAD, the Direct Marketing Association, The Ad Council, HotJobs and the advisory board of Doctors Without Borders. He holds a B.A. from Yale University and an M.B.A. from INSEAD.


Kevin Ryan
Board Member
AlleyCorp
Jay Rughani is a partner on the Bio + Health investing team, where he focuses on software, data, and marketplace companies across healthcare and life sciences.Prior to a16z, Jay worked at Flatiron Health (acquired by Roche). There, he helped to build some of the company’s first data & analytics software products used by biopharmaceutical companies to study real-world cancer care. He went on to develop numerous commercial partnerships with large biopharma companies, smaller biotechs, and other research organizations.Previously, Jay advised large healthcare and technology organizations on corporate growth initiatives at Deloitte and supported various go-to-market, product, and fundraising efforts at DealerMatch (acquired by Cox Enterprises).
Jay received a B.A. in Mathematics & Economics at Emory University and grew up in Clearwater, FL, and London, UK.


Jay Rughani
Board Member
a16z










































































































































